Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Rena Fox, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address1545 Divisadero
    San Francisco CA 94115
    Phone415-514-8656
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      Stanford UniversityB.A.Human Biology1991
      Bryn Mawr CollegePost-Baccalaureate1992
      University of California San DiegoM.D.School of Medicine1997
      University of WashingtonInternship and ResidencyInternal Medicine2000
      UCSFClinician-Educator FellowshipGeneral Internal Medicine2001

      Collapse Overview 
      Collapse Overview
      Dr. Rena Fox is a Professor of Medicine at University of California, San Francisco (UCSF). She has been on the faculty in the Division of General Internal Medicine for 16 years. Dr. Fox was an undergraduate at Stanford, got her MD at UC San Diego and did her internal medicine residency at University of Washington. She was a general medicine fellow at UCSF with an interest in hepatitis C during which time she was trained by UCSF hepatologists in viral hepatitis and since then, Dr. Fox has been the sole faculty member at UCSF who is both an expert in hepatitis C and is a general internist, and is one of the few people in the country in this unique position. Dr. Fox is internationally recognized as an educator – she lectures around the country and she has been working with the Veterans Administration for a decade on hepatitis C educational tools, national policies and as the Medical Editor of the VA Viral Hepatitis Website. As part of the DHHS Hepatitis Action Plan, and the CDC aim to educate the country’s physicians in hepatitis C, she is on a national advisory board with the University of Washington, creating an online hepatitis C curriculum for HCV education. She is a co-author and panel member of the clinical practice guidelines for the VA regarding the use of hepatitis C drugs. She served as a clinical expert for the California Technology Assessment Forum (CTAF) meetings on hepatitis C drugs in 2014. As a researcher, she studies hepatitis C epidemiology and clinical outcomes, including long term outcomes of hepatocellular carcinoma and cirrhosis in large multicenter studies. Dr. Fox trains UCSF medical students and Internal Medicine residents. She sees patients in two settings – she has a large panel of primary care patients at the UCSF General Medicine practice, and she treats hepatitis C patients at the Liver Clinic at UCSF.


      Collapse ORNG Applications 
      Collapse Websites
      Collapse In The News

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Fox RK, Muniraj T. Pharmacologic Therapies in Gastrointestinal Diseases. Med Clin North Am. 2016 Jul; 100(4):827-50. PMID: 27235617.
        View in: PubMed
      2. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan 1; 176(1):65-73. PMID: 26595724.
        View in: PubMed
      3. Kaplan DE, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Knott A, Pedrosa M, Pocha C, Mehta R, Duggal M, Skanderson M, Valderrama A, Taddei T. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2333-2341.e6. PMID: 26188137; PMCID: PMC4655141 [Available on 12/01/16].
      4. Fox RK. Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists. Dig Dis Sci. 2015 Sep; 60(9):2576-8. PMID: 25986522.
        View in: PubMed
      5. Shah AD, Fox RK, Rushakoff RJ. Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone. Endocr Pract. 2014 Nov; 20(11):e229-32. PMID: 25100400; PMCID: PMC4423899.
      6. Fox RK. When to consider liver transplant during the management of chronic liver disease. Med Clin North Am. 2014 Jan; 98(1):153-68. PMID: 24266919.
        View in: PubMed
      7. Fox RK. Hepatitis B--more treatments, more testing, not enough data. J Gen Intern Med. 2011 Mar; 26(3):232-3. PMID: 21267669; PMCID: PMC3043180.
      8. Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol. 2007 Oct; 47(4):527-37. PMID: 17692986.
        View in: PubMed
      9. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86. PMID: 15983913.
        View in: PubMed
      10. Seligman HK, Fox RK. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2002 Apr 4; 346(14):1091-2. PMID: 11936120.
        View in: PubMed
      Rena's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP